# hl7.fhir.uv.vulcan-schedule#2.0.0-ballot: Clinical Study Schedule of Activities(en)

## Pages

* [Home](en/index.md)
* [Examples](en/examples.md)
* [Changes](en/changes.md)
* [Visit Windowing](en/visit-windows.md)
* [Acknowledgements](en/credits.md)
* [Conditional Activities](en/dynamic-conditional-activities.md)
* [Downloads](en/downloads.md)
* [Unscheduled Visits](en/dynamic-unscheduled-visits.md)
* [Dynamic Features](en/dynamic.md)
* [Artifacts Summary](en/artifacts.md)
* [Core Schedule of Activities Model](en/basic-structure.md)
* [Investigational Product Administration](en/ip-administration.md)
* [Use case for integration using CDISC ODM](en/cdisc-odm.md)
* [Dynamic Visit Plans](en/dynamic-visit-plans.md)
* [Profiles](en/profiles.md)

## Resources

### Resource Profiles

* [PlannedStudyVisitSoa](en/StructureDefinition-PlannedStudyVisitSoa.md)
* [ResearchStudySoa](en/StructureDefinition-ResearchStudySoa.md)
* [StudyActivitySoa](en/StructureDefinition-StudyActivitySoa.md)
* [StudyProtocolSoa](en/StructureDefinition-StudyProtocolSoa.md)
* [StudyVisitSoa](en/StructureDefinition-StudyVisitSoa.md)
* [SOA PlanDefinition](en/StructureDefinition-soaPlanDefinition.md)

### Extensions

* [Acceptable Offset Range](en/StructureDefinition-AcceptableOffsetRangeSoa.md)
* [SoA TimePoint Specification](en/StructureDefinition-soaTimepoint.md)
* [SoA Transition Specification](en/StructureDefinition-soaTransition.md)

### ImplementationGuides

* [Clinical Study Schedule of Activities](en/ImplementationGuide-hl7.fhir.uv.vulcan-schedule.md)

### Examples

* [Vital Signs - Temperature (ActivityDefinition)](en/ActivityDefinition-H2Q-MC-LZZT-Vital-Signs-Temperature.md)
* [EliLillyAndCompany (Organization)](en/Organization-EliLillyAndCompany.md)
* [H2Q-MC-LZZT Protocol Schedule of Activities (PlanDefinition)](en/PlanDefinition-H2Q-MC-LZZT-ProtocolDesign.md)
* [H2Q-MC-LZZT Screening Visit (PlanDefinition)](en/PlanDefinition-H2Q-MC-LZZT-Study-Visit-1.md)
* [H2Q-MC-LZZT Baseline/First Study Treatment Visit (PlanDefinition)](en/PlanDefinition-H2Q-MC-LZZT-Study-Visit-3.md)
* [Levothroxine-Monitoring-Schedule (PlanDefinition)](en/PlanDefinition-Levothroxine-Monitoring-Schedule.md)
* [Levothroxine-Monitoring-Titration-Activities (PlanDefinition)](en/PlanDefinition-Levothroxine-Monitoring-Titration-Activities.md)
* [dynamic-visit-schedule-exit-example-PlanDefinition (PlanDefinition)](en/PlanDefinition-dynamic-visit-schedule-exit-example-PlanDefinition.md)
* [dynamic-visit-schedule-multiple-paths (PlanDefinition)](en/PlanDefinition-dynamic-visit-schedule-multiple-paths.md)
* [dynamic-visit-schedules-cycles-scheduled-interactions (PlanDefinition)](en/PlanDefinition-dynamic-visit-schedules-cycles-scheduled-interactions.md)
* [SamGetWell (Practitioner)](en/Practitioner-SamGetWell.md)
* [Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimer’s Disease (ResearchStudy)](en/ResearchStudy-H2Q-MC-LZZT-ResearchStudy.md)
